Arca
Skip to content
Tools
Tools

CYP11A1: Cholesterol side-chain cleavage enzyme, mitochondrial

A cytochrome P450 monooxygenase that catalyzes the side-chain hydroxylation and cleavage of cholesterol to pregnenolone, the precursor of most steroid hormones.

  • Drugs that act on it: 3
  • Approved: 3
  • In phases 1 to 3: 0
  • Sponsors: 3

Who is on it, and how far along

Every drug ChEMBL records acting on CYP11A1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 3

Approved3

  • Mitotane
  • Aminoglutethimide
  • Levoketoconazole

Phase 30

    Phase 20

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Cytochrome P450 11A1 inhibitor.
        MitotaneBoxed warningApprovedEsteveSmall moleculeInhibitor9
        AminoglutethimideApprovedNovartis PharmaceuticalsSmall moleculeInhibitor0
        LevoketoconazoleBoxed warningApprovedStrongbridgeSmall moleculeInhibitor0

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 8 in all, from ClinicalTrials.gov.
        Cemiplimab as Maintenance Treatment for Advanced Adrenocortical CancerMitotanePhase 2RecruitingAzienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaJul 25, 2025
        Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical CarcinomaMitotanePhase 2RecruitingWest China HospitalFeb 17, 2025
        Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical CarcinomaMitotanePhase 1RecruitingNational Cancer Institute (NCI)Jul 5, 2024
        Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIMitotanePhase 2RecruitingUNICANCERMar 27, 2024
        Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)MitotanePhase 2RecruitingAzienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaJun 22, 2023
        Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical CarcinomaMitotanePhase 2Active, not recruitingNational Cancer Center, KoreaSep 5, 2021
        Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of RecurrenceMitotanePhase 3RecruitingM.D. Anderson Cancer CenterJul 11, 2018
        Evaluation of Side Effects of MitotaneMitotane—Active, not recruitingUniversity of WuerzburgDec 5, 2007

        Diseases most associated with it

        Open Targets association score, 0 to 1; all associations
        • Congenital adrenal insufficiency with 46, XY sex reversal OR 46,XY disorder of sex development-adrenal insufficiency due to CYP11A1 deficiency0.80
        • Adrenal cortex carcinoma0.52
        • Neoplasm0.49
        • Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency0.46
        • Inherited isolated adrenal insufficiency due to partial CYP11A1 deficiency0.38
        • Adrenal cortex neoplasm0.37
        • Adrenal gland hyperfunction0.37
        • Adrenal gland disorder0.37
        • Wilson disease0.30

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2033, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. Gene name, function (UniProt P05108, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.